Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
75,700
+800 (1.07%)
At close: Feb 26, 2026
Market Cap623.50B +64.7%
Revenue (ttm)14.90B +70.6%
Net Income-117.78M
EPS-606.21
Shares Out8.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume57,746
Average Volume101,745
Open76,300
Previous Close74,900
Day's Range73,200 - 76,700
52-Week Range35,600 - 101,000
Betan/a
RSI49.01
Earnings DateMar 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements